Tifluadom
Изглед
IUPAC ime | |
---|---|
N-[(5-(2-fluorophenyl)- 1-methyl- 2,3-dihydro- 1,4-benzodiazepin-2-yl) methyl] thiophene- 3-carboxamide | |
Klinički podaci | |
Način primene | oralno |
Identifikatori | |
CAS broj | 83386-35-0 |
ATC kod | none |
PubChem | CID 115208 |
IUPHAR/BPS | 1667 |
ChemSpider | 103084 |
KEGG | D02694 |
ChEMBL | CHEMBL169703 |
Hemijski podaci | |
Formula | C22H20FN3OS |
Molarna masa | 393.477 g/mol |
| |
|
Tifluadom je benzodiazepinski derivat. Za razliku od većine benzodiazepina, tifluadom ne deluje kao GABAA agonist, nego je selektivni agonist
Dok tifluadom ima više efekata koji potencijalno mogu da nađu medicinsku primenu, kao što su analgezija i stimulacija apetita, on je
Vidi još
[уреди | уреди извор]Reference
[уреди | уреди извор]- ^ Romer D, Buscher HH, Hill RC, Maurer R, Petcher TJ, Zeugner H, Benson W, Finner E, Milkowski W, Thies PW. Unexpected opioid activity in a known class of drug. Life Sciences. 1982 Sep 20-27;31(12-13):1217-20.
- ^ Genovese RF, Dykstra LA. Tifluadom's effects under electric shock titration and tail-immersion procedures in squirrel monkeys. Life Sciences. 1986 Nov 10;39(19):1713-9.
- ^ Leander JD. Kappa opioid agonists and antagonists: effects on drinking and urinary output. Appetite. 1984 Mar;5(1):7-14.
- ^ Jackson HC, Sewell RD. The role of opioid receptor sub-types in tifluadom-induced feeding. Journal of Pharmacy and Pharmacology. 1984 Oct;36(10):683-6.
- ^ Dykstra LA, Gmerek DE, Winger G, Woods JH. Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. Journal of Pharmacology and Experimental Therapeutics. 1987 Aug;242(2):413-20.
Spoljašnje veze
[уреди | уреди извор]
Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |